Log in to search using one of your social media accounts:

 

Wider sampling of tumor tissues may guide drug choice, improve outcomes
This study challenges current guidelines and supports evaluation of metastatic lesions and circulating tumor DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Cancer Doctors Cite Risks of Drinking Alcohol
Drinking alcohol, even modest amounts, increases the risk of breast cancer and other cancers. (Source: NYT Health)
Source: NYT Health - November 7, 2017 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Head and Neck Cancer Breast Cancer Esophageal Cancer Mouth Colon and Colorectal Cancer Liver Cancer Alcoholic Beverages Alcohol Abuse Advertising and Marketing Source Type: news

Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news

Aspirin 'cuts risk of cancer by up to half'
A trial involving more than half a million people found long-term aspirin users cut their risk of liver and oesophageal cancer by almost half, while their odds of getting bowel cancer fell by a quarter. (Source: the Mail online | Health)
Source: the Mail online | Health - October 31, 2017 Category: Consumer Health News Source Type: news

Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent
(Spink Health) In a study involving over 600,000 people, those prescribed with aspirin showed a 47 percent reduction in liver and esophageal cancer incidence, a 38 percent reduction in gastric cancer incidence, a 34 percent reduction in pancreatic cancer incidence and a 24 percent reduction in colorectal cancer incidence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
(Mayo Clinic) A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 24, 2017 Category: Cancer & Oncology Source Type: news

Proton therapy may be better option for elderly patients with esophageal cancer
CHICAGO ? A study led by Mayo Clinic researchers has found that proton beam therapy, in combination with chemotherapy, prior to surgery, may be a better option than a combination using traditional radiation therapy techniques with chemotherapy when treating elderly patients with esophageal cancer. Standard X-ray radiation therapy techniques include 3-D conformal radiation and intensity-modulated [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - October 24, 2017 Category: Databases & Libraries Source Type: news

Electronic Nose Promising for Barrett's Esophagus Detection
(MedPage Today) -- Test may facilitate surveillance for esophageal adenocarcinoma (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - October 17, 2017 Category: Gastroenterology Source Type: news

Esophageal cancer 'cell of origin' identified
(Columbia University Medical Center) Researchers at Columbia University Medical Center have identified cells in the upper digestive tract that can give rise to Barrett's esophagus, a precursor to esophageal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 11, 2017 Category: Cancer & Oncology Source Type: news

Zinc supplements found to protect against esophageal cancer
(Natural News) A new study finds that zinc supplements can help prevent cancer in the esophagus, as reported by Science Daily. Researchers at the University of Texas at Arlington (UTA) evaluated the reaction of human esophageal cancer cells and healthy human cells to zinc. They discovered that zinc supplements slowed down the growth of esophageal cancer... (Source: NaturalNews.com)
Source: NaturalNews.com - October 8, 2017 Category: Consumer Health News Source Type: news

New studies add to understanding of treatments for Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) The October issue of GIE: Gastrointestinal Endoscopy features several new studies evaluating various treatments for Barrett's esophagus (BE). BE is a condition in which there are unusual changes to the cells lining the esophagus. It is believed to be most commonly due to inflammation from gastroesophageal reflux disease (GERD). Sometimes these changes may be considered precancerous. Endoscopic treatments for BE focus on removing or destroying the problematic tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 6, 2017 Category: Cancer & Oncology Source Type: news

First patient treated with CSA Medical ’ s AV spray catheter
CSA Medical said today that the first patient was treated using the company’s new rapid AV spray catheter for the management of persistent symptomatic esophageal cancer and associated dysplastic Barrett’s disease. The device uses a stainless steel catheter wall to cut the time needed to deliver liquid nitrogen spray to the treatment site by 50%, the company said. It was recently cleared for use with CSA Medical’s truFreeze system – a cryosurgical tool used to ablate benign and malignant lesions. Get the full story at our sister site, Drug Delivery Business News. The post First patient treated w...
Source: Mass Device - October 3, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Surgical CSA Medical Inc. Source Type: news

Medical News Today: Zinc may help to prevent, treat esophageal cancer
Zinc can halt the growth of esophageal cancer cells by inhibiting overactive calcium signaling, according to the results of a new study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 29, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Cancer breakthrough: Taking THIS supplement could halt growth of deadly cells
CANCER of the oesophagus is a deadly condition, with symptoms including indigestion and difficulty swallowing. But taking a regular zinc supplement could stop cancerous cells in their tracks. (Source: Daily Express - Health)
Source: Daily Express - Health - September 29, 2017 Category: Consumer Health News Source Type: news

UTA study says zinc can halt the growth of cancer cells
(University of Texas at Arlington) Zinc supplements can significantly inhibit the proliferation of esophageal cancer cells, according to a new study co-authored by a University of Texas at Arlington researcher. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 28, 2017 Category: Cancer & Oncology Source Type: news

Cernostics Announces Leadership Team Expansion
New Commercial Leader Positions Company for Continued Success and Growth BETHLEHEM and PITTSBURGH, Pa., Sept. 12, 2017 -- (Healthcare Sales & Marketing Network) -- Cernostics, a privately-held diagnostics company focused on delivering next-generation c... Diagnostics, Oncology, Personnel Cernostics, TissueCypher, Barrett's Esophagus, esophageal cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 12, 2017 Category: Pharmaceuticals Source Type: news

Drinks industry accused of downplaying 'alcohol-cancer risk'
Conclusion This qualitative analysis aimed to determine the accuracy of health information circulated by the alcohol industry on the links between alcohol and cancer. It found the industry and affiliated organisations use three main approaches: denial of the link between alcohol and cancer misinterpretation of the risk distraction by focusing on other risk factors This analysis highlights how these strategies could be detrimental to public health. Of course, it's possible, given this data was collected in 2016, that some of the websites and documents analysed by the researchers have since been updated. Regardless, the...
Source: NHS News Feed - September 8, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

MIRO: Minimally Invasive Surgery for Esophageal Cancer MIRO: Minimally Invasive Surgery for Esophageal Cancer
Patients with resectable esophageal cancer should undergo hybrid minimally invasive surgery, urge experts after a trial showed it markedly reduce postoperative morbidity vs open surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Consider plant-based diet for treating reflux symptoms
PPIs no better than plant-based Mediterranean diet plus alkaline water at improving LPR symptoms, research suggests Related items fromOnMedica Oesophageal and stomach cancer linked to early adulthood overweight Plant protein consumption linked to increased longevity Plant-based diet not always best for heart health (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news

MIRO trial: 3-year outcomes favor laparoscopic surgery for esophageal cancer
(European Society for Medical Oncology) Patients requiring surgery for esophageal cancer fare better after undergoing a hybrid minimally invasive esophagectomy compared to an open esophagectomy, according to long-term results of the MIRO trial to be presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 4, 2017 Category: Cancer & Oncology Source Type: news

CSA Medical wins another FDA expansion for TruFreeze cryotherapy
Endoscopic cryo-ablation company CSA Medical said today it won expanded FDA 510(k) clearance for its TruFreeze spray cryotherapy system, now cleared for use on patients with Barrett’s esophagus with low grade dysplasia. With the clearance, the device is now approved for both low and high grade dysplasia as well as malignancies, the Boston-based company said. “Over the past few years, studies have underscored the potential risk for Barrett’s esophagus with low grade dysplasia to progress to esophageal adenocarcinoma. Intervening at this level of dysplasia has become common practice and is recogni...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Otolaryngology Ear, Nose & Throat Regulatory/Compliance CSA Medical Inc. Source Type: news

CSA Medical Announces Expansion of truFreeze(R) Label to Include Barrett's Esophagus with Low Grade Dysplasia
From Barrett's Esophagus to Malignancy - Only truFreeze® BOSTON, Aug. 31, 2017 -- (Healthcare Sales & Marketing Network) -- CSA Medical announced on Thursday, the expansion of its truFreeze® label with the addition of Barrett's Esophagus with l... Devices, Interventional, FDA CSA Medical, truFreeze, Barrett's Esophagus, cryotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 31, 2017 Category: Pharmaceuticals Source Type: news

ICR researchers discover use of ibrutinib drug to attack oesophageal cancer cells
Scientists from the UK Institute of Cancer Research (ICR) have identified an existing drug, ibrutinib, which could be effective against oesophageal cancers. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 23, 2017 Category: Pharmaceuticals Source Type: news

In Esophageal Cancer, Women Have Stronger Responses In Esophageal Cancer, Women Have Stronger Responses
Chemoradiotherapy followed by surgery is standard of care for locally advanced esophageal cancer, but how the sexes respond to treatment is not uniform.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Cancer survival: Current treatment for THIS deadly type works better in women
CANCER treatment tends to be the same for men and women, but a new study on oesophageal cancer has found that treating genders differently may be more effective. (Source: Daily Express - Health)
Source: Daily Express - Health - August 23, 2017 Category: Consumer Health News Source Type: news

Oesophageal cancer breakthrough: New way to attack deadly cells revealed
OESOPHAGEAL cancer - or cancer of the gullet - could be treated with a existing drug in a new way, experts have found. (Source: Daily Express - Health)
Source: Daily Express - Health - August 22, 2017 Category: Consumer Health News Source Type: news

Females Show Better Response to CRT in Esophageal Cancer
Females more often had complete, nearly complete pathologic response to induction tx; less recurrence (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 22, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Large study reveals women have superior response to esophageal cancer treatment
(Elsevier) Female patients with locally advanced esophageal cancer that is treated with chemotherapy and radiation therapy before surgery are more likely to have a favorable response to the treatment than male patients are, and women are less likely to experience cancer recurrence, according to a study published online today in The Annals of Thoracic Surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2017 Category: International Medicine & Public Health Source Type: news

Scientists uncover a deadly 'addiction' in esophageal cancer
(Institute of Cancer Research) Scientists have discovered a new way of attacking esophageal cancer cells that could make use of an existing drug in a new approach to treatment. Their study discovered a genetic weakness or 'Achilles' heel' in esophageal cancer cells that makes them particularly sensitive to a drug called ibrutinib which is already used to treat blood cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 22, 2017 Category: Cancer & Oncology Source Type: news

Periodontal Disease Linked to Certain Cancer Types
In this interview we discuss a recent study that linked periodontal disease with an increased cancer risk, specifically melanoma and cancers of the lung, breast, esophagus, and gallbladder. (Source: CancerNetwork)
Source: CancerNetwork - August 18, 2017 Category: Cancer & Oncology Authors: Jean Wactawski-Wende, PhD Source Type: news

'Junk food' may increase cancer risk in 'healthy weight' women
"Women who eat junk food such as burgers or pizza are increasing their risk of cancer even if they're not overweight, new research has warned," reports the Daily Mail. The story is based on research from the US looking at the diet of postmenopausal women in the 1990s and then tracking the development of a variety of cancers over about 15 years. "Junk food" is often defined as food that is rich in calories (energy dense food) but low in nutrients. Having a diet high in energy dense foods, such as biscuits, chocolate and pizza was found to increase the risk of cancer in these women, specifically in those ...
Source: NHS News Feed - August 18, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Men more likely the target for esophageal cancer
About 17,000 people in the U.S. are diagnosed with esophageal cancer each year – more than 13,000 are men. It affects the esophagus – a long tube that sends food and liquids from your throat to your stomach. Esophageal cancer can make it difficult to eat and affect your quality of life. Here are ways how to reduce your risk of the disease. Age, gender, race, and weight a re risk factors – The most common type of esophageal cancer is called adenocarcinoma. It begins in the lower part of the… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 14, 2017 Category: American Health Authors: Dr. Ghulam Abbas Source Type: news

Men more likely the target for esophageal cancer
About 17,000 people in the U.S. are diagnosed with esophageal cancer each year – more than 13,000 are men. It affects the esophagus – a long tube that sends food and liquids from your throat to your stomach. Esophageal cancer can make it difficult to eat and affect your quality of life. Here are ways how to reduce your risk of the disease. Age, gender, race, and weight a re risk factors – The most common type of esophageal cancer is called adenocarcinoma. It begins in the lower part of the… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 14, 2017 Category: Biotechnology Authors: Dr. Ghulam Abbas Source Type: news

7 medtech stories we missed this week: August 11, 2017
[Image from unsplash.com]From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions for the Calix-C cervical inter body cages. The clearance allows for two larger footprints to be added for use with allograft. The Calix-C Cervical Interbody Spacer is designed for spinal fusion procedures at level one in patients who are skeletally m...
Source: Mass Device - August 11, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Cardiovascular Clinical Trials Food & Drug Administration (FDA) Oncology Regulatory/Compliance Spinal Surgical Apifix Cardiac Science Hip Innovation Life Spine Inc. MedTech Pentax Medical Varian Medical Systems Xtant M Source Type: news

Robots offer key advantages in esophageal surgery
(Allina Health) Robotics provide better visuals and allow lymph node removal with fewer incisions. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 11, 2017 Category: Cancer & Oncology Source Type: news

First patient treated with Biostage ’ s esophageal implant
Biostage (NSDQ:BSTG) touted today the first patient use of its Cellspan esophageal implant. The Holliston, Mass.-based company said that the regenerative implant was used in a 75-year old male patient, who has a life-threatening cancerous mass in his chest. Surgeons removed the portion of his esophagus affected by the cancer and Biostage’s implant was used to reconstruct the organ. The patient is alive three months after his surgery on May 4, according to Biostage. “We are encouraged by the ongoing success of the Cellspan esophageal implant in our first in-patient case, and we look forward to additional opportu...
Source: Mass Device - August 7, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Implants Oncology Regenerative Medicine Biostage Source Type: news

FDA Drug Safety Communication: Ongoing safety review of oral osteoporosis drugs (bisphosphonates) and potential increased risk of esophageal cancer
[07-21-2011] The U.S. Food and Drug Administration (FDA) is continuing to review data from published studies to evaluate whether use of oral bisphosphonate drugs is associated with an increased risk of cancer of the esophagus (esophageal cancer). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 4, 2017 Category: Drugs & Pharmacology Source Type: news

Gum Disease Tied to Cancer Risk in Older Women
Periodontal disease was associated with an increased risk of esophageal and gallbladder cancers, cancers of the breast and lung, and melanoma. (Source: NYT Health)
Source: NYT Health - August 2, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Smoking and Tobacco Teeth and Dentistry Gums (Mouth) Cancer Gallbladder Melanomas Source Type: news

Periodontal Disease History Linked to Increased Cancer Risk
For older women, risk of total cancer, melanoma, and breast, lung, esophagus, gallbladder cancers up (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - August 2, 2017 Category: Respiratory Medicine Tags: Dermatology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Internal Medicine, Nursing, Oncology, Pathology, Pulmonology, Radiology, Surgery, Journal, Source Type: news

Gum Disease May Be Linked to Cancer Risk in Older Women
Esophageal, breast and lung cancer, among others, seen in postmenopausal women in large study (Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - August 2, 2017 Category: Cancer & Oncology Source Type: news

Gum Disease Linked to Cancer Risk in Older Women?
Esophageal, breast and lung cancer, among others, seen in postmenopausal women in large study (Source: WebMD Health)
Source: WebMD Health - August 1, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Women with gum disease may need to watch out for cancer
A new study finds associations between gum disease in women over 54 and many different types of cancer, including gallbladder cancer and esophageal cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 1, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Gum Disease May Be Linked to Cancer Risk in Older Women
Esophageal, breast and lung cancer, among others, seen in postmenopausal women in large study (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 1, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Dentistry, News, Source Type: news

Gum Disease May Be Linked to Cancer Risk in Older Women
Esophageal, breast and lung cancer, among others, seen in postmenopausal women in large study Source: HealthDay Related MedlinePlus Pages: Cancer, Gum Disease, Women's Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 1, 2017 Category: Consumer Health News Source Type: news

Gum disease raises the risk of cancer by up to 14%
Researchers from the University of Buffalo found that periodontal disease is significantly associated with an increased risk of developing esophageal and gallbladder cancer in postmenopausal women. (Source: the Mail online | Health)
Source: the Mail online | Health - August 1, 2017 Category: Consumer Health News Source Type: news

Results of NRG-RTOG 0436 highlight need for biomarkers in treatment of esophageal cancer
(NRG Oncology) NRG-RTOG 0436 has determined that adding an epidermal growth factor receptor (EGFR) inhibitor to a chemo-radiation regimen does not improve overall survival for patients with locally advanced esophageal cancer treated in a non-operative manner. These results are reported in 'Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients with Esophageal Cancer -- The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical Trial,' which was recently published in the Journal of the American Medical Association Oncology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 25, 2017 Category: International Medicine & Public Health Source Type: news

The six deadliest cancers: THIS is how long patients are expected to live
PANCREATIC cancer, liver cancer, lung cancer, oesophageal cancer - or cancer of the gullet - and stomach cancer are among the deadliest forms of cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - July 19, 2017 Category: Consumer Health News Source Type: news

The six deadliest cancers: How long patients are expected to live REVEALED
PANCREATIC cancer, liver cancer, lung cancer, oesophageal cancer - or cancer of the gullet - and stomach cancer are among the deadliest forms of cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - July 19, 2017 Category: Consumer Health News Source Type: news

CSA Medical wins expanded FDA nod for TruFreeze system
Endoscopic cryo-ablation company CSA Medical said today it won FDA 510(k) clearance for a 3rd spray kit, the rapid AV spray kit, for its TruFreeze system. The Boston-based company’s TruFreeze system is designed as a cryosurgical tool designed for use in dermatology, gynecology, general surgery and to ablate benign and malignant lesions. The newly cleared addition is designed to shorten the time to liquid nitrogen spray by 50%, the company said. The company touted the TruFreeze device as the only ablation technology designed to ablate Barrett’s Esophagus with a high grade dysplasia or cancers as such a...
Source: Mass Device - July 17, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Catheters Food & Drug Administration (FDA) Regulatory/Compliance CSA Medical Inc. Source Type: news

7 medtech stories we missed this week: July 14, 2017
[Image from unsplash.com]From Novarad touting its VR-surgical guidance system to Zynex paying off its $2.2M loan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Stimwave announces first patient in Brazil Stimwave announced in a July 5 press release that its first patients in Brazil have received Stimwave’s wireless pain relief device treatment for chronic pain. The patients are expected to receive the neuromodulation treatment as an alternative to opioid pain relief. The devices created by Stimwave deliver small pulses of energy to specific nerves to trigger a reac...
Source: Mass Device - July 14, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Clinical Trials Diabetes Diagnostics Imaging Neuromodulation/Neurostimulation Pain Management Research & Development American Red Cross Nemaura Medical Novarad Owlstone Medical Stimwave Tactical Medical Zynex Inc. Source Type: news